Search Results - "L. Gubieras"

Association of HLA-DRB115 allele and CSF oligoclonal bands in a Spanish multiple sclerosis cohort by Romero-Pinel, L., Martínez-Yélamos, S., Bau, L., Matas, E., Gubieras, L., María Pujal, J., Morandeira, F., Bas, J., Arbizu, T.

“…Background and objective:  The HLA‐DRB1*15 allele is consistently associated with multiple sclerosis (MS) susceptibility in most studied populations. This…”
Get full text

Direct costs of relapses in patients with relapsing-remitting multiple sclerosis by V. Casado, I. Bonaventura, L. Brieva, S. Martínez-Yélamos, G. Martín, S. Presas-Rodriguez, M. Hervas, J.J. Hernández, E. Munteis, A. Escartin, L. Gubieras, M.A. Mañé-Martínez, L. Ramió-Torrentà

“…Introduction: Effective treatments that reduce relapses can diminish the impact on MS costs in the long-term. This study aims to estimate direct costs of RRMS…”
Get full text

HLA-DRB1: genetic susceptibility and disability progression in a Spanish multiple sclerosis population by Romero-Pinel, L., Pujal, J. M., Martínez-Yélamos, S., Gubieras, L., Matas, E., Bau, L., Torrabadella, M., Azqueta, C., Arbizu, T.

“…Background and objective:  The association of HLA‐DRB1*15 with susceptibility to multiple sclerosis (MS) has been consistently reported although its effect on…”
Get full text

Anticipation of age at onset in familial multiple sclerosis by Romero-Pinel, L., Martínez-Yélamos, S., Gubieras, L., Matas, E., Bau, L., Kremenchutzky, M., Arbizu, T.

“…Background and objective:  Anticipation of age at onset in the younger generations is a widely known characteristic of many diseases with genetic inheritance…”
Get full text

PND23 Cost of the Informal Care of Multiple Sclerosis in Spain by Gubieras, L, Casado, V, Romero-Pinel, L, Matas, E, Bau, L, Martínez-Yélamos, S, Arbizu, T

Get full text

PND19 Cost Of The Relapse Of Multiple Sclerosis In Spain by Gubieras, L, Casado, V, Romero-Pinel, L, Matas, E, Bau, L, Martínez-Yélamos, S, López, M, Escartín, A, Arbizu, T

Get full text

Anticipation of age at onset in multiple sclerosis: methodologic pitfalls by Alonso-Magdalena, L., Romero-Pinel, L., Moral, E., Carmona, O., Gubieras, L., Ramón, J. M., Martínez-Yélamos, S., Arbizu, T.

“…Alonso‐Magdalena L, Romero‐Pinel L, Moral E, Carmona O, Gubieras L, Ramón JM, Martínez‐Yélamos S, Arbizu T. Anticipation of age at onset in multiple sclerosis:…”
Get full text

An approach to estimating the intangible costs of multiple sclerosis according to disability in Catalonia, Spain by Casado, V., Romero, L., Gubieras, L., Alonso, L., Moral, E., Martinez-Yelamos, S., Martinez-Yelamos, A., Carmona, O., Arbizu, T.

“…Multiple sclerosis (MS) is a chronic demyelinating disease, which represents a great economic burden to society. Cost-of-illness studies of MS tend to…”
Get full text

Interferon-beta and autoinmune hepatitis in multiple sclerosis: cause-effect or association? by Carmona, O, Gubieras, L, Romero-Pinel, L, Alonso-Magdalena, L, Moral, E, Casado, V, Arbizu, T

Get more information

Anticipation of age at onset in multiple sclerosis: methodologic pitfalls: Anticipation in multiple sclerosis by Alonso-Magdalena, L., Romero-Pinel, L., Moral, E., Carmona, O., Gubieras, L., Ramón, J. M., Martínez-Yélamos, S., Arbizu, T.

Get full text

Direct costs of relapses in patients with relapsing-remitting multiple sclerosis by Casado, V., Bonaventura, I., Brieva, L., Martínez-Yélamos, S., Martín, G., Presas-Rodriguez, S., Hervas, M., Hernández, J.J., Munteis, E., Escartin, A., Gubieras, L., Mañé-Martínez, M.A., Ramió-Torrentà, L.

“…Effective treatments that reduce relapses can diminish the impact on MS costs in the long-term. This study aims to estimate direct costs of RRMS relapses in…”
Get full text